Kalyra Pharmaceuticals Inc is a biopharmaceutical company developing medicines that address unmet needs in the area of pain management, anti-infectives and fibrosis. The company has developed proprietary chemical building blocks, or bioisosteres, to enable efficient drug reconstruction. Using the developed bioisosteres, we are able to create drugs with improved properties at lower risk, cost and in less time than traditional drug development. Applications of drugs include a new non-addictive therapy for pain management, new treatments for drug resistant microbial infection, and emerging diseases such as fibrosis.
